Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome
Sergio Martínez-Høyer, Yu Deng, Jeremy Parker, Jihong Jiang, Angela Mo, Roderick Docking, Nadia Gharaee, Jenny Li, Patricia Umlandt, Megan Fuller, Martin Jädersten, Austin Kulasekararaj, Luca Malcovati, Alan F. List, Eva Hellström‐Lindberg, Uwe Platzbecker, Aly Karsan
Topics & Concepts
RUNX1Cancer researchBiologyMyelodysplastic syndromesGATA2Context (archaeology)MutationMolecular biologyImmunologyGeneticsStem cellBone marrowHaematopoiesisGenePaleontologyProtein Degradation and InhibitorsAcute Myeloid Leukemia ResearchMultiple Myeloma Research and Treatments